* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Section 2: ß-Cell Genes: Functional Aspects
Transposable element wikipedia , lookup
Public health genomics wikipedia , lookup
Genomic imprinting wikipedia , lookup
Oncogenomics wikipedia , lookup
Saethre–Chotzen syndrome wikipedia , lookup
Short interspersed nuclear elements (SINEs) wikipedia , lookup
Neuronal ceroid lipofuscinosis wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Genetic engineering wikipedia , lookup
Non-coding DNA wikipedia , lookup
Genome (book) wikipedia , lookup
Genome evolution wikipedia , lookup
Epigenetics of depression wikipedia , lookup
Gene therapy wikipedia , lookup
History of genetic engineering wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
Epigenetics in learning and memory wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Gene nomenclature wikipedia , lookup
Helitron (biology) wikipedia , lookup
Transcription factor wikipedia , lookup
Primary transcript wikipedia , lookup
Microevolution wikipedia , lookup
Point mutation wikipedia , lookup
Gene desert wikipedia , lookup
Epigenetics of human development wikipedia , lookup
Long non-coding RNA wikipedia , lookup
Gene expression programming wikipedia , lookup
Mir-92 microRNA precursor family wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Gene expression profiling wikipedia , lookup
Designer baby wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Section 2: -Cell Genes: Functional Aspects Regulation of pdx-1 Gene Expression Danielle Melloul, Sonya Marshak, and Erol Cerasi The homeodomain-containing transcription factor pancreatic duodenal homeobox 1 (PDX-1) plays a key role in pancreas development and in -cell function. Upstream sequences of the gene up to about ⴚ6 kb show islet-specific activity in transgenic mice. Attempts to identify functional regulatory elements involved in the controlled expression of the pdx-1 gene led to the identification of distinct distal -cell–specific enhancers in human and rat genes. Three additional sequences, conserved between the mouse and the human 5ⴕ-flanking regions, two of which are also found in the chicken gene, conferred -cell–specific expression on a reporter gene, albeit to different extents. A number of transcription factors binding to and modulating the transcriptional activity of the regulatory elements were identified, such as hepatocyte nuclear factor (HNF)-3, HNF-1␣, SP1/3, and, interestingly, PDX-1 itself. A fourth conserved region was localized to the proximal promoter around an E-box motif and was found to bind members of the upstream stimulatory factor (USF) family of transcription factors. We postulate that disruption of pdx-1 cis-acting regulatory sequences and/or mutations or functional impairment of transcription factors controlling the expression of the gene can lead to diabetes. Diabetes 51 (Suppl. 3):S320 –S325, 2002 P ancreatic duodenal homeobox 1 (PDX-1) is an orphan homeodomain protein that plays an important role in pancreas development. It is initially detected on embryonic day 8.5 in the part of the dorsal and ventral primitive gut epithelium that later develops into the pancreas. A high expression is maintained in most epithelial cells of the pancreatic bud until day embryonic day 10.5 and then decreases to later reappear predominantly in the differentiated -cell. Targeted inactivation of this gene in the mouse (1,2) as well as its mutation in humans (3) result in agenesis of the pancreas. In the mouse model, malformations in areas within the duodenum and absence of Brunner’s glands were observed (1,2,4,5). Although pdx-1 gene expression does not appear to be required for pancreatic determina- From the Department of Endocrinology and Metabolism, Hadassah University Hospital, Jerusalem, Israel. Address correspondence and reprint requests to Dr. Danielle Melloul, Department of Endocrinology, Hadassah University Hospital, P.O. Box 12 000, Jerusalem 91120. E-mail: [email protected]. Received for publication 16 April 2002 and accepted in revised form 8 May 2002. HNF, hepatocyte nuclear factor; MODY, maturity-onset diabetes of the young; PDX-1, pancreatic duodenal homeobox 1. The symposium and the publication of this article have been made possible by an unrestricted educational grant from Servier, Paris. S320 tion of the endoderm, it is crucial for the development of endocrine and exocrine cell types (2,6). Differentiation and maintenance of the -cell phenotype also require PDX-1. In mice, -cell–selective disruption of pdx-1 led to the development of diabetes with increasing age and was associated with reduced insulin and GLUT2 expression (7). Indeed, mice heterozygous for pdx-1 were found to be glucose intolerant (7,8). In transgenic mice expressing an antisense ribozyme specific for mouse pdx-1 in the -cells, the expression of the endogenous gene was decreased and followed by impaired glucose tolerance and elevated glycated hemoglobin levels (9). Impaired expression of PDX-1 as a consequence of hyperglycemia or increased lipid concentrations (10) is associated with diabetes. In humans, a subpopulation of type 2 diabetes is monogenic and carries mutations in genes important for normal -cell function. Heterozygous individuals carrying one of the mutant genes develop a form of maturity-onset diabetes of the young (MODY). MODY4 has been linked to heterozygosity for mutations in pdx-1 (11,12). Other monogenic forms of MODY have been associated with mutations in genes coding for transcription factors hepatocyte nuclear factor (HNF)-1␣, HNF-1, HNF-4␣, and Beta2 (13), most of which will be described below as regulators of pdx-1 gene transcription. Together, these data indicate that PDX-1 has a dosage-dependent regulatory effect on the expression of -cell–specific genes and therefore assists in the maintenance of euglycemia. As a consequence, mutations or functional impairment of other transcription factors that control the expression of the pdx-1 gene in the -cell could result in additional subtypes of MODY or be candidates for susceptibility to diabetes. Because PDX-1 appears to play such a central role in -cell differentiation and function, as well as in pancreatic regeneration (14), understanding the molecular basis of its regulation and its maintained expression in the -cell will enable the identification of factors that govern these processes. STRUCTURE OF THE pdx-1 GENE The coding region of the pdx-1 gene comprises two exons. The first exon encodes for the NH2-terminal region of PDX-1, and the second encodes for the homeodomain and COOH-terminal domain. The human, mouse, and rat genes are localized on chromosomes 13 (15,16), 5 (17), and 12 (18), respectively. Although the activation domain of PDX-1 is contained within the NH2-terminal domain, its homeodomain is involved in DNA binding; both are involved in protein–protein interactions (19 –25). The pdx-1 gene is TATA-less; thus, it utilizes three principal tranDIABETES, VOL. 51, SUPPLEMENT 3, DECEMBER 2002 D. MELLOUL, S. MARSHAK, AND E. CERASI scription initiation sites (17), followed by a short 5⬘ untranslated sequence of ⬃100 nucleotides. REGULATION OF pdx-1 EXPRESSION Distal rat and human pdx-1 enhancer elements. To understand the mechanisms that control the expression of PDX-1 during pancreas development and in the adult -cell, the pdx-1 gene from different species was mapped. Regulatory regions lying upstream from the transcription start sites are under characterization in transgenic mice as well as in cultured cells in several laboratories. A genomic fragment containing ⬃6.5 kb of the 5⬘-flanking rat pdx-1 sequence was sufficient to target -galactosidase expression to pancreatic islets and duodenal cells in transgenic mice (17). A longer fragment containing the coding region and the 3⬘-flanking sequences of the gene restored the development of all pancreatic lineages and corrected glucose intolerance in pdx-1⫺/⫺ animals (24). In transiently transfected -cells, the fragment extending from ⫺6.2 to ⫹68 linked to a reporter gene showed 20- to 100-fold higher activity than that in non-islet cells. Using deletion analyses, the -cell–specific regulated expression of the rat sequence appeared to require a distal enhancer element located between the ⫺6.2- and ⫺5.67-kb region of the gene. This element was shown to bind the endodermal factors HNF-3 and Beta2, which act cooperatively to induce PDX-1 expression. Furthermore, glucocorticoids reduced pdx-1 gene expression by interfering with HNF-3 activity on the islet enhancer (26). To characterize the regulatory elements and potential transcription factors necessary for the expression of human pdx-1 in -cells, a series of 5⬘ and 3⬘ deletion fragments of a 7-kb sequence of the 5⬘-flanking region of the gene, fused to a reporter gene, was tested. By transient transfections in -cells and non–-cells, a -cell–specific distal enhancer element located between ⫺3.7 and ⫺3.45 kb was delineated. This enhancer fragment strongly stimulated reporter gene activity in all -cell lines tested and was much less active in non–-cells, including glucagonproducing cells, and in acinar and hepatic cells. No sequence similarity was revealed between the enhancer sequence and the available mouse or rat pdx-1 genomic sequences. DNase I footprinting analysis revealed two protected regions: one binding the transcription factors SP1 and SP3 and another binding HNF-3 and HNF-1␣. Similar to the rat distal enhancer, these factors act in concert to regulate the transcriptional activity of the pdx-1 gene (27). Human and mouse pdx-1 conserved regulatory elements. In vivo characterization of the mouse pdx-1 sequences was independently initiated using a fragment of ⬃4.5 kb upstream of the initiation start site (28 –30). The transgene driven by these sequences was shown to approximately recapitulate the endogenous expression pattern. An extended fragment containing the coding region, 3 kb of the 3⬘-flanking region, and 6.2 kb of upstream sequences was able to completely rescue the apancreatic pdx-1 null phenotype and ultimately restore glucose homeostasis. Moreover, the sequences sufficient for appropriate developmental and islet-specific expression were located within ⬃4.5 kb of 5⬘-flanking DNA (30). The -galactosidase was detected in Brunner’s glands of the DIABETES, VOL. 51, SUPPLEMENT 3, DECEMBER 2002 proximal duodenum and pyloric glands of the distal stomach and coincided with the expression of pdx-1 mRNA. Occasionally, ectopic activity was observed in exocrine tissue of the adult pancreas, submucosal layer of the duodenum, and even in the spleen (28). Failure of the pancreas to develop in both humans and mice lacking PDX-1, as well as the dosage-dependent effect of PDX-1 on the expression of -cell–specific genes (and on the maintenance of euglycemia), led to the assumption that sequences conserved between the two species could be essential for its transcriptional control. A striking divergence at the nucleotide level was observed between the two species with the exception of four regions that showed significant (94, 81, 73, and 78%) similarity. In addition to the conserved proximal promoter sequence (20), three short highly homologous regions were found between ⫺2.81 and ⫺1.67 kb of the human and between ⫺2.7 and ⫺1.8 kb of the mouse pdx-1 gene (Fig. 1). These regions were designated PH1, PH2, and PH3 for PDX-1 homologous regions 1–3 (22) or areas I, II, and III, as determined by Gerrish et al. (31). In transient transfection experiments, each of the conserved sequences was able to confer -cell–specific activity on a heterologous promoter; however, it was done to different extents. PH1/areaI and PH2/areaII showed the highest preferential induction in -cell versus non–-cell activity (22,31). An interesting observation was the absence of the PH2/areaII domain in the chicken 5⬘-flanking region (31), suggesting that the regulation of pdx-1 expression in birds may differ from that in rodents and humans. Attempting to identify factors that regulate the transcriptional activity of the conserved domains, DNase I footprinting analyses, gel electrophoretic mobility shift assays and mutational studies led to the identification of several transcription factors (Fig. 1). PH1/areaI and PH2/ areaII sequences bind and are transactivated by HNF-3. Although mutations in the HNF-3 binding site within the PH2/areaII sequence did not modify its transcriptional activity, in PH1/areaI, it had a profound effect. Interestingly, the PH1/areaI enhancer element was reported to bind the PDX-1 transcription factor itself both in vitro (22) and in vivo (32), suggesting a possible autoregulatory loop as a mechanism for PDX-1 to control its own expression. The involvement of HNF-1␣ in regulating PH1/areaI was also determined (32). It was further shown that the PDX-1 protein binds HNF-3, and all three transcription factors appear to act cooperatively to regulate transcription. Identification of factors binding and regulating conserved sequence PH3 is the focus of ongoing studies. Thus, from the studies on the binding and the cooperativity between the different factors acting in concert to control the transcriptional activity of pdx-1 regulatory elements, it emerges that at least some aspects of the expression of the gene rely on the transcription factor HNF-3. Indeed, its absence in mouse embryonic stem cells had a profound effect on pdx-1 gene expression (29). HNF-3 is a member of the forkhead/winged helix family of transcription factors and is essential for endodermal cell lineages (33,34). It is structurally related to histone H5, which can alter the nucleosomal structure and thus prime target genes for expression by opening the chromatin structure and providing promoter access to other tranS321 pdx-1 GENE EXPRESSION FIG. 1. Organization of mouse, human, and rat pdx-1 enhancer/promoter regions. cis-acting regulatory elements of the pdx-1 5ⴕ-flanking sequences are boxed. Conserved sequences between human, mouse, and rat pdx-1 genes are indicated as dark boxes and nonconserved enhancer elements as empty boxes. A: DNA fragments of the mouse pdx-1 gene used in transgenic mice experiments in their expression patterns are depicted (28 –30). B: Transcription factors binding to the regulatory elements are indicated above each box. PH1, PH2, and PH3 equals PDX-1 homology regions 1, 2, and 3, respectively. scription factors (35,36). Because HNF-3 is not restricted to -cells, the selective transcription of PDX-1 is likely to rely on the combination of additional factors, among them HNF-1␣, SP1, PDX-1 itself, and possibly other unidentified factors. In addition, the distal human enhancer element and the PH1/areaI domain bind the HNF-1 members of transcription factors. HNF-1␣ and HNF-1 homeoproteins are capable of binding the HNF-1 site as homodimers or heterodimers (37,38). Transient transfection experiments in fibroblasts demonstrated that both HNF-3 and HNF-1␣ independently activate the distal human enhancer and, when cotransfected, act in a synergistic manner. However, HNF-1 did not affect enhancer-driven transcription separately or in combination with HNF-3. Although high levels of HNF-1 mRNA are observed at 6 –7.5 days of gestation (39), HNF-1␣ is expressed at a later developmental stage (40) and appears to be the predominant form present in adult -cells (27). We found that the relative abundance of HNF-1␣ and HNF- proteins differ in various pancreatic cell lines, suggesting that differences in HNF-1 subtype ratios may be one of the factors contributing to tissue-specific expression of the pdx-1 gene. The relative abundance of the two major HNF-1 species was recently suggested to be a mechanism for expression pattern S322 determination for the glut-2 gene (41). The in vivo studies on HNF-1␣ knockout mice did not give an unequivocal answer regarding the importance of this transcription factor for pdx-1 gene expression. Shih et al. (42) reported that in HNF-1␣ null animals’ pdx-1 mRNA levels were significantly decreased (42); however, little or no effect on its expression was obtained by Parrizas et al. (43). Furthermore, no reduction in PDX-1 protein was observed in transgenic mice with selective expression of a dominantnegative form of HNF-1␣ in pancreatic -cells (44). Mutations in the HNF-1␣ gene represent the most frequent form of MODY (45). The observed diabetic phenotype was first suggested to be the result of impaired binding of HNF-1␣ to the insulin promoter, thus causing decreased transcriptional activity of the gene. However, binding of HNF-1␣ to the flanking AT sequences (FLAT)-F element of the insulin gene appears to be unique to the rat insulin I gene because this AT-rich motif is not conserved among insulin promoter sequences. In fact, HNF-1␣ is a weak transactivator of the human insulin gene; we therefore favor the explanation that the impact on insulin gene expression is indirect, via its effect on pdx-1 gene transcription. Impaired pancreatic function in MODY3 is also the result of defective transcription of genes involved in -cell glucose sensing and glucose metabolism (42). DIABETES, VOL. 51, SUPPLEMENT 3, DECEMBER 2002 D. MELLOUL, S. MARSHAK, AND E. CERASI FIG. 2. The proximal promoter of the mouse, human, and rat pdx-1 gene. Sequence homology between the proximal region of the TATA-less rat, mouse, and human pdx-1 genes. The sequences corresponding to the transcription start sites (S1–S3) are highly conserved and indicated as determined for the rat gene (17). The in vivo importance of the conserved domains was addressed in transgenic mice (28 –30). Fragment XbaI– XhoI, spanning the sequence between ⫺4.3 and ⫺1.88 kb of the mouse pdx-1 gene, which includes both PH1/areaI and PH2/areaII domains, directed the transgene expres‘sion to pancreatic islets but not to any other cell population in which PDX-1 is normally expressed. However, a smaller region (PstI–BstEII) that still contained PH1/areaI and PH2/areaII sequences was active in the islets as well as in the pyloric sphincter and the common bile duct. Furthermore, within the pancreas, expression of the reporter gene driven by the PstI–BstEII fragment was found in the majority of insulin-, glucagon-, and somatostatinproducing cells; therefore, this fragment was considered to be an endocrine-specific enhancer. Furthermore, the fragment (XhoI–BglII) containing PH3/areaIII drove the reporter expression to clusters of insulin-producing cells, whereas it was almost inactive in glucagon- and somatostatin-positive cells of the neonatal pancreas. However, this -cell–specific activity was transient and lost in adult pancreases (30). Although the reason for the silencing of this transgene is not clear, it may be proposed that the XhoI–BglII region plays a specific role in immature -cells or provides critical developmental cues for the initiation of the mature -cell lineage. Altogether, these data suggest that the conserved domains confer islet-specific, and to a certain extent -cell–specific, transcription both in vivo and in vitro. However, separately or in combination, these elements cannot faithfully recapitulate the expression of endogenous pdx-1, thus implicating that additional regulatory elements must be involved in this process. Mutations or deletions of important regulatory sequences in the context of the endogenous pdx-1 gene will help assess their critical importance in the regulated expression of the gene. THE PROXIMAL PROMOTER OF THE pdx-1 GENE As mentioned earlier, the pdx-1 gene is TATA-less, and although the sequences corresponding to the transcription start sites among the rat, mouse, and human genes are highly conserved (17) (Fig. 2), great heterogeneity is revealed further upstream. The -cell–specific transcripDIABETES, VOL. 51, SUPPLEMENT 3, DECEMBER 2002 tional regulation of the rat pdx-1 gene was reported to rely in part on a proximal promoter sequence containing an E-box motif located at ⫺104. Pursuing our search for functional regulatory elements in the human pdx-1 5⬘flanking region, deletion analysis of the proximal promoter was performed, and a -cell–specific regulatory sequence between ⫺160 and ⫺100 bp was identified. Comparison of this region between the promoters of insulin genes from different origins showed a relatively high degree of homology (78%), with greater heterogeneity further upstream. DNAse I footprinting, using the conserved proximal promoter of the human gene and -cell extracts, revealed a specific protected region around the conserved E-box motif (CACGTG) (17). This site predominantly binds a complex containing the transcription factor USF (17). Mutations abolishing its binding impaired the activity of the pdx-1 promoter. Expression of a dominant-negative form of USF-2 in -cells reduced both the pdx-1 promoter activity as well as PDX-1 mRNA and protein levels. This led to a reduction of PDX-1 binding to the insulin promoter and consequently a dramatic decrease in insulin gene expression (46). Thus, USF1 and USF2 interactions with the E-box sequence in the pdx-1 promoter appear to contribute to the preferential expression of the gene in -cells. DISCUSSION Taken together, these results suggest that the transcriptional stimulation of pdx-1 in -cells is mediated by a unique combination of protein–protein interactions and that separate modules in the gene can be active at a given stage by binding a specific set of transcription factors. Indeed, the transcription factors HNF-3, HNF-1␣, HNF1, SP1/3, USF1/2, and PDX-1 itself regulate the expression of the pdx-1 gene. Most of these factors have been previously shown, mainly by knockout experiments in mice, to be important developmental regulators. PDX-1 is a key factor with multiple functions both during development and in the differentiated -cell. In the adult, its role in regulating islet-specific genes and, most importantly, in mediating the glucose effect on insulin gene transcription S323 pdx-1 GENE EXPRESSION emphasizes its particular role in normal and diabetic states. ACKNOWLEDGMENTS The study was supported by the Juvenile Diabetes Research Foundation International (1-2001-325). The authors wish to express their gratitude to Tamara Gurevich, Michal Shoshkes, and Etti BenShushan for their contributions. REFERENCES 1. Jonsson J, Carlsson L, Edlund T, Edlund H: Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 371:606 – 609, 1994 2. Offield MF, Jetton TL, Labosky PA, Ray M, Stein RW, Magnuson MA, Hogan BL, Wright CV: PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122:983–995, 1996 3. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF: Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 15:106 –110, 1997 4. Guz Y, Montminy MR, Stein R, Leonard J, Gamer LW, Wright CV, Teitelman G: Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development 121:11–18, 1995 5. Larsson LI, Madsen OD, Serup P, Jonsson J, Edlund H: Pancreaticduodenal homeobox 1: role in gastric endocrine patterning. Mech Dev 60:175–184, 1996 6. Ahlgren U, Jonsson J, Edlund H: The morphogenesis of the pancreatic mesenchyme is uncoupled from that of the pancreatic epithelium in IPF1/PDX1-deficient mice. Development 122:1409 –1416, 1996 7. Ahlgren U, Jonsson J, Jonsson L, Simu K, Edlund H: Beta-cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev 12:1763–1768, 1998 8. Brissova M, Shiota M, Nicholson WE, Gannon M, Knobel SM, Piston DW, Wright CV, Powers AC: Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion. J Biol Chem 277:11225– 11232, 2002 9. Thomas MK, Devon ON, Lee JH, Peter A, Schlosser DA, Tenser MS, Habener JF: Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1. J Clin Invest 108:319 –329, 2001 10. Melloul D, Marshak S, Cerasi E: Regulation of insulin gene transcription. Diabetologia 45:309 –326, 2002 11. Stoffers DA, Ferrer J, Clarke WL, Habener JF: Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 17:138 –139, 1997 12. Stoffers DA, Stanojevic V, Habener JF: Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein. J Clin Invest 102:232–241, 1998 13. Fajans SS, Bell GI, Polonsky KS: Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345:971–980, 2001 14. Sharma A, Zangen DH, Reitz P, Taneja M, Lissauer ME, Miller CP, Weir GC, Habener JF, Bonner-Weir S: The homeodomain protein IDX-1 increases after an early burst of proliferation during pancreatic regeneration. Diabetes 48:507–513, 1999 15. Stoffel M, Stein R, Wright CV, Espinosa R III, Le Beau MM, Bell GI: Localization of human homeodomain transcription factor insulin promoter factor 1 (IPF1) to chromosome band 13q12.1. Genomics 28:125–126, 1995 16. Inoue H, Riggs AC, Tanizawa Y, Ueda K, Kuwano A, Liu L, Donis-Keller H, Permutt MA: Isolation, characterization, and chromosomal mapping of the human insulin promoter factor 1 (IPF-1) gene. Diabetes 45:789 –794, 1996 17. Sharma S, Leonard J, Lee S, Chapman HD, Leiter EH, Montminy MR: Pancreatic islet expression of the homeobox factor STF-1 relies on an E-box motif that binds USF. J Biol Chem 271:2294 –2299, 1996 18. Yokoi N, Serikawa T, Walther R: Pdx1, a homeodomain transcription factor required for pancreas development, maps to rat chromosome 12. Exp Anim 46:323–324, 1997 19. Asahara H, Dutta S, Kao HY, Evans RM, Montminy M: Pbx-Hox heterodimers recruit coactivator-corepressor complexes in an isoform-specific manner. Mol Cell Biol 19:8219 – 8225, 1999 20. Peers B, Leonard J, Sharma S, Teitelman G, Montminy MR: Insulin expression in pancreatic islet cells relies on cooperative interactions between the helix loop helix factor E47 and the homeobox factor STF-1. Mol Endocrinol 8:1798 –1806, 1994 S324 21. Peers B, Sharma S, Johnson T, Kamps M, Monteminy M: The pancreatic islet factor STF-1 binds cooperatively with Pbx to a regulatory element in the somatostatin promoter: importance of the FPWMK motif and of the homeodomain. Mol Cell Biol 15:7091–7097, 1995 22. Marshak S, Benshushan E, Shoshkes M, Havin L, Cerasi E, Melloul D: Functional conservation of regulatory elements in the pdx-1 gene: PDX-1 and hepatocyte nuclear factor 3beta transcription factors mediate betacell-specific expression. Mol Cell Biol 20:7583–7590, 2000 23. Glick E, Leshkowitz D, Walker MD: Transcription factor BETA2 acts cooperatively with E2A and PDX1 to activate the insulin gene promoter. J Biol Chem 275:2199 –2204, 2000 24. Dutta S, Gannon M, Peers B, Wright C, Bonner-Weir S, Montminy M: PDX:PBX complexes are required for normal proliferation of pancreatic cells during development. Proc Natl Acad Sci U S A 98:1065–1070, 2001 25. Qiu Y, Guo M, Huang S, Stein R: Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47. Mol Cell Biol 22:412– 420, 2002 26. Sharma S, Jhala US, Johnson T, Ferreri K, Leonard J, Montminy M: Hormonal regulation of an islet-specific enhancer in the pancreatic homeobox gene STF-1. Mol Cell Biol 17:2598 –2604, 1997 27. Ben-Shushan E, Marshak S, Shoshkes M, Cerasi E, Melloul D: A pancreatic beta-cell-specific enhancer in the human PDX-1 gene is regulated by hepatocyte nuclear factor 3beta (HNF-3beta), HNF-1alpha, and SPs transcription factors. J Biol Chem 276:17533–17540, 2001 28. Stoffers DA, Heller RS, Miller CP, Habener JF: Developmental expression of the homeodomain protein IDX-1 in mice transgenic for an IDX-1 promoter/lacZ transcriptional reporter. Endocrinology 140:5374–5381, 1999 29. Wu KL, Gannon M, Peshavaria M, Offield MF, Henderson E, Ray M, Marks A, Gamer LW, Wright CV, Stein R: Hepatocyte nuclear factor 3beta is involved in pancreatic beta-cell-specific transcription of the pdx-1 gene. Mol Cell Biol 17:6002– 6013, 1997 30. Gannon M, Gamer LW, Wright CV: Regulatory regions driving developmental and tissue-specific expression of the essential pancreatic gene pdx1. Dev Biol 238:185–201, 2001 31. Gerrish K, Gannon M, Shih D, Henderson E, Stoffel M, Wright CV, Stein R: Pancreatic beta cell-specific transcription of the pdx-1 gene: the role of conserved upstream control regions and their hepatic nuclear factor 3beta sites. J Biol Chem 275:3485–3492, 2000 32. Gerrish K, Cissell MA, Stein R: The role of hepatic nuclear factor 1 alpha and PDX-1 in transcriptional regulation of the pdx-1 gene. J Biol Chem 276:47775– 47784, 2001 33. Zaret KS: Molecular genetics of early liver development. Annu Rev Physiol 58:231–251, 1996 34. Gualdi R, Bossard P, Zheng M, Hamada Y, Coleman JR, Zaret KS: Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control. Genes Dev 10:1670 –1682, 1996 35. Shim EY, Woodcock C, Zaret KS: Nucleosome positioning by the winged helix transcription factor HNF3. Genes Dev 12:5–10, 1998 36. Clark KL, Halay ED, Lai E, Burley SK: Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 364:412– 420, 1993 37. Mendel DB, Hansen LP, Graves MK, Conley PB, Crabtree GR: HNF-1 alpha and HNF-1 beta (vHNF-1) share dimerization and homeo domains, but not activation domains, and form heterodimers in vitro. Genes Dev 5:1042– 1056, 1991 38. Bach I, Mattei MG, Cereghini S, Yaniv M: Two members of an HNF1 homeoprotein family are expressed in human liver. Nucleic Acids Res 19:3553–3559, 1991 39. Cereghini S, Ott MO, Power S, Maury M: Expression patterns of vHNF1 and HNF1 homeoproteins in early postimplantation embryos suggest distinct and sequential developmental roles. Development 116:783–797, 1992 40. Boj SF, Parrizas M, Maestro MA, Ferrer J: A transcription factor regulatory circuit in differentiated pancreatic cells. Proc Natl Acad Sci U S A 98:14481–14486, 2001 41. Cha JY, Kim H, Kim KS, Hur MW, Ahn Y: Identification of transacting factors responsible for the tissue-specific expression of human glucose transporter type 2 isoform gene: cooperative role of hepatocyte nuclear factors 1alpha and 3beta. J Biol Chem 275:18358 –18365, 2000 42. Shih DQ, Screenan S, Munoz KN, Philipson L, Pontoglio M, Yaniv M, Polonsky KS, Stoffel M: Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes 50:2472–2480, 2001 43. Parrizas M, Maestro MA, Boj SF, Paniagua A, Casamitjana R, Gomis R, Rivera F, Ferrer J: Hepatic nuclear factor 1-alpha directs nucleosomal hyperacetylation to its tissue-specific transcriptional targets. Mol Cell Biol 21:3234 –3243, 2001 DIABETES, VOL. 51, SUPPLEMENT 3, DECEMBER 2002 D. MELLOUL, S. MARSHAK, AND E. CERASI 44. Yamagata K, Nammo T, Moriwaki M, Ihara A, Iizuka K, Yang Q, Satoh T, Li M, Uenaka R, Okita K, Iwahashi H, Zhu Q, Cao Y, Imagawa A, Tochino Y, Hanafusa T, Miyagawa J, Matsuzawa Y: Overexpression of dominantnegative mutant hepatocyte nuclear fctor-1 alpha in pancreatic beta-cells causes abnormal islet architecture with decreased expression of Ecadherin, reduced beta-cell proliferation, and diabetes. Diabetes 51:114 – 123, 2002 45. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam DIABETES, VOL. 51, SUPPLEMENT 3, DECEMBER 2002 L, Cox RD, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Bell GI, et al.: Mutations in the hepatocyte nuclear factor-1alpha gene in maturity- onset diabetes of the young (MODY3). Nature 384:455– 458, 1996 46. Qian J, Kaytor EN, Towle HC, Olson LK: Upstream stimulatory factor regulates Pdx-1 gene expression in differentiated pancreatic beta-cells. Biochem J 341:315–322, 1999 S325